Results 31 to 40 of about 130,119 (244)

A-56 | Genotype vs Conventional Guided P2Y12 Inhibitor in Post-PCI Patients: A Meta-Analysis and Systematic Review

open access: closedJournal of the Society for Cardiovascular Angiography & Interventions, 2023
Neel Patel   +10 more
openalex   +2 more sources

Effect of SGLT2 inhibitor on patients with STEMI complicated with type 2 diabetes mellitus after PCI [PDF]

open access: yesXin yixue, 2023
Objective To evaluate the effect of sodium-glucose cotransporter-2 inhibitor (SGLT2i) on the efficacy and safety of percutaneous coronary intervention (PCI) in patients with acute ST segment elevation myocardial infarction (STEMI) complicated with type 2
Du Shengli, Jia Zengqin, Zhang Qihua
doaj   +1 more source

TCT-520 Real-world Clinical Outcomes of Bioresorbable Vascular Scaffold Versus Conventional Drug Eluting Stents in Primary-PCI for ST-elevation Myocardial Infarction: single center one-year experience

open access: bronzeJournal of the American College of Cardiology, 2015
Quentin de Hemptinne   +4 more
openalex   +3 more sources

A Novel Robotic Control System Mimics Doctor’s Operation to Assist Percutaneous Coronary Intervention

open access: yesCardiovascular Innovations and Applications, 2022
Objectives: The use of current robotic systems to assist in percutaneous coronary intervention (PCI) fundamentally differs from performing conventional PCI.
Boda Zhou   +7 more
doaj   +1 more source

Quality of Life After Percutaneous Coronary Intervention in No-Touch Saphenous Vein Grafts is Significantly Better Than in Conventional Vein Grafts [PDF]

open access: yesBrazilian Journal of Cardiovascular Surgery, 2022
Objective: To compare health-related quality of life (HRQoL) of patients primarily treated with a no-touch saphenous vein graft with that of patients who received a conventional graft.
Gabriele Ferrari   +5 more
doaj   +1 more source

P2Y12 inhibitor monotherapy after complex percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials

open access: yesScientific Reports, 2023
It remains unknown whether the recent trend of short dual antiplatelet therapy (DAPT) followed by P2Y12 inhibitor monotherapy can simply be applied to patients undergoing complex percutaneous coronary intervention (PCI).
Yohei Sotomi   +11 more
doaj   +1 more source

Design considerations for an ultrahigh-bandwidth Phase 6 Contrast Imaging system applied to fusion grade devices [PDF]

open access: yesJINST 18 C10005 (2023), 2023
The PCI diagnostic is an internal reference interferometer that creates an image of absolutely calibrated electron density fluctuations integrated along the line of sight of the probing light beam. While conventional PCI diagnostics installed on fusion experiments worldwide employ light of wavelength equal to 10.59 $\mu$~m, the same system using light ...
arxiv   +1 more source

C-REACTIVE PROTEIN IN NON-ST ELEVATION MYOCARDIAL INFARCTION PATIENTS IS USEFUL IN IMPROVING DISCRIMINATION OF CONVENTIONAL RISK SCORE: A REPORT FROM MULTICENTER PCI REGISTRY

open access: closedJournal of the American College of Cardiology, 2017
Toshiomi Katsuki   +12 more
openalex   +3 more sources

Short-term outcome after percutaneous coronary intervention in patients with impaired left ventricular systolic function by conventional, tissue Doppler, and speckle-tracking echocardiographic study

open access: yesAl-Azhar Assiut Medical Journal, 2020
Background Myocardial revascularization with chronic left ventricular (LV) dysfunction improved LV functional and survival. Echocardiographic (echo) remains the test for assessing cardiac function in clinical practice.
Mohamed M Ahmed
doaj   +1 more source

Home - About - Disclaimer - Privacy